{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:58:47Z","timestamp":1794031127696,"version":"4.8.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo Europe GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.numecd.2025.104412","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:56:29Z","timestamp":1760504189000},"page":"104412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort"],"prefix":"10.1016","volume":"36","author":[{"given":"Marcello","family":"Arca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Solini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Gambacurta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-2094","authenticated-orcid":false,"given":"Alberico L.","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2025.104412_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106814","article-title":"The burden of hypercholesterolemia and ischemic heart disease in an ageing world","volume":"193","author":"Pirillo","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.numecd.2025.104412_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2025.104412_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2025.104412_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2025.104412_bib5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-Wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","volume":"28","author":"Ray","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2025.104412_bib6","first-page":"e49","volume":"vol. 42","author":"Landmesser","year":"2020"},{"key":"10.1016\/j.numecd.2025.104412_bib7","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.numecd.2025.104412_bib8","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/eurjpc\/zwae199","article-title":"Use of combination therapy is associated with improved LDL cholesterol management: 1-Year follow-up results from the European observational SANTORINI study","volume":"31","author":"Ray","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2025.104412_bib9","first-page":"1","article-title":"Lipid-lowering treatment and LDL-C goal attainment in high and very high cardiovascular risk patients: evidence from the SANTORINI study-the Italian experience","volume":"2","author":"Arca","year":"2023","journal-title":"Eur Ath J"},{"key":"10.1016\/j.numecd.2025.104412_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104412_bib11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2025.104412_bib12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.numecd.2024.05.002","article-title":"Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian society for the study of atherosclerosis (SISA)","volume":"34","author":"Tarugi","year":"2024","journal-title":"Nutr Metabol Cardiovasc Dis : Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2025.104412_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/eurjpc\/zwac251","article-title":"Underutilization of combination therapy in lipid lowering: a missed opportunity","volume":"30","author":"Sener","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2025.104412_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14020493","article-title":"Therapeutic inertia in dyslipidemia management for secondary cardiovascular prevention: results from the Italian ITACARE-P network","volume":"14","author":"Faggiano","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.numecd.2025.104412_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010335","article-title":"Pragmatic trial of messaging to providers about treatment of hyperlipidemia (PROMPT-LIPID): a randomized clinical trial","volume":"17","author":"Shah","year":"2024","journal-title":"Circulation Cardiovascular quality and outcomes"},{"key":"10.1016\/j.numecd.2025.104412_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MCA.0000000000001407","article-title":"Cardiovascular benefits of statin plus ezetimibe combination therapy versus statin monotherapy in acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"36","author":"de Oliveira Almeida","year":"2025","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.numecd.2025.104412_bib17","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/eurjpc\/zwac107","article-title":"Achievement of ESC\/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab","volume":"29","author":"Landmesser","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2025.104412_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamacardio.2020.0882","article-title":"Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: a prespecified secondary analysis from the FOURIER trial","volume":"5","author":"Gencer","year":"2020","journal-title":"JAMA Cardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325005678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325005678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:40:50Z","timestamp":1773254450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325005678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0939475325005678"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104412","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104412"}}